Canadian Association for Independent Clinical Research

L'association Canadienne pour la recherche clinique independante

  • Showcasing the advantages and strengths of independent research sites in Canada.
  • Educating global sponsors regarding the many advantages of running research in Canada
  • Support initiatives to educate patients regarding clinical research.
  • Actively participate in efforts to improve patient participation in clinics research
  • Communicating our collective successes to the industry. 
  • Advocating for improvements in clinical research in Canada.
  • Identifying industry improvement opportunities.
  • Proposing systemic changes to benefit the Canadian research environment and supporting the implementation of such improvements.

2.  Attracting new clinical studies to Canada:

3.  Patient Engagement:

CAICR/ACRCI is a non-profit association.


1.  Representation of our stakeholders by:


In the summer of 2012, a working group of major organizations, drawn from the independent clinical research community in Canada, came together in response to the ever changing and evolving global clinical trial environment. The working group recognized that there is a multitude of independent clinical research sites and organizations across Canada, and through collaboration, greater value to the clinical trial industry in Canada can be achieved.

Close to 63% of all clinical research that is conducted in Canada is conducted at independent research centres.  With thousands of independent physicians and research study staff across Canada, working diligently to advance medical science, the group of stakeholders are joining together to represent, support, and advocate for this sector. This concept leverages the collective talents and capabilities of the members and is pivotal for the industry and its future.

CAICR/ACRCI seeks representation, support, and input from independent clinical research organizations across Canada. This will range from phase I to phase IV research studies (including Investigator Initiated Research), and will cover diverse therapeutic areas from family medicine to specialty medicine (diabetes, CNS, nutraceuticals, etc.). We welcome input or suggestions from existing, and prospective members in order to collaboratively make CAICR/ACRCI a preferred destination for global clinical studies.